Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity, Atlas Biolabs Ink Software Agreement

Premium

Atlas Biolabs said this week that it has signed a collaborative agreement with Ingenuity Systems so that it can provide its customers with the option to analyze and interpret their study data with Ingenuity's products.

Specifically, customers will have access to Ingenuity Variant Analysis (BI 1/13/2012), which is used to identify causal variants in whole genome and exome sequencing experiments; and iReport which is used to analyze RNA-seq and other gene expression data (BI 1/30/2012).

Both solutions leverage Ingenuity Knowledge Base, which is a repository of biological interactions and functional annotations created from individually modeled relationships between proteins, genes, complexes, cells, tissues, metabolites, drugs, and diseases.

Sean Scott, Ingenuity's senior vice president for global commercial operations, said in a statement that the partnership will provide customers with "a complete sample-to-insight solution" that combines Atlas' lab services with Ingenuity's analysis and biological interpretation solutions.

“The Ingenuity products facilitate and accelerate the bioinformatics support we provide to our customers," Karsten Heidtke, Atlas' head of bioinformatics added.

"They allow us and our customers to interactively maneuver through the data and shed light on it from multiple biological perspectives to understand the biological meaning,” he said.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.